Percutaneous hepatic melphalan perfusion: Single center experience of procedural characteristics, hemodynamic response, complications, and postoperative recovery.
<h4>Background</h4>Percutaneous hepatic melphalan perfusion (PHMP) for the selective treatment of hepatic metastases is known to be associated with procedural hypotension and coagulation disorders. Studies on anesthetic management, perioperative course, complications, and postoperative r...
Guardado en:
Autores principales: | Manuel Florian Struck, Peter Kliem, Sebastian Ebel, Alice Bauer, Holger Gössmann, Rhea Veelken, Florian van Bömmel, Timm Dennecke, Sebastian N Stehr, Felix F Girrbach |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da2fd030c8994fa3a9253011c037c514 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Role of Hemodynamic Support in High-risk Percutaneous Coronary Intervention
por: Charles Simonton, et al.
Publicado: (2020) -
DIAGNOSIS OF HEMODYNAMIC CHANGES OF THE LIVER IN CONDITIONS OF BILIARY HYPERTENSION WITH PERFUSION COMPUTED TOMOGRAPHY
por: V. A. Malakhanov, et al.
Publicado: (2017) -
Percutaneous nephrolithotomy; alarming variables for postoperative bleeding
por: Shakhawan H.A. Said, et al.
Publicado: (2017) -
Long-term outcomes of busulfan plus melphalan-based versus melphalan 200 mg/m2 conditioning regimens for autologous hematopoietic stem cell transplantation in patients with multiple myeloma: a systematic review and meta-analysis
por: Fei Gao, et al.
Publicado: (2021) -
Generation of a predictive melphalan resistance index by drug screen of B-cell cancer cell lines.
por: Martin Boegsted, et al.
Publicado: (2011)